AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Aquestive Therapeutics, a pharmaceutical company, will participate in the Piper Sandler 37th Annual Healthcare Conference. The Aquestive team will hold a fireside chat with Piper Sandler Sr. Research Analyst David Amsellem on December 4, 2025, focusing on Anaphylm (dibutepinephrine) sublingual film, including regulatory progress and commercial readiness. Management will also host investor meetings. A webcast of the fireside chat will be available on the company's website.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet